Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.82M P/E - EPS this Y - Ern Qtrly Grth -
Income -6.53M Forward P/E 2.18 EPS next Y - 50D Avg Chg -11.00%
Sales 5.9M PEG - EPS past 5Y - 200D Avg Chg -39.00%
Dividend N/A Price/Book 0.35 EPS next 5Y 15.00% 52W High Chg -78.00%
Recommedations 2.00 Quick Ratio 14.93 Shares Outstanding 1.99M 52W Low Chg 4.00%
Insider Own 17.26% ROA -19.39% Shares Float 1.66M Beta 2.32
Inst Own 5.68% ROE -30.06% Shares Shorted/Prior 1.15K/23.21K Price 0.87
Gross Margin 66.89% Profit Margin -110.64% Avg. Volume 111,624 Target Price -
Oper. Margin -140.93% Earnings Date May 1 Volume 44,611 Change -2.62%
About NeuroMetrix, Inc.

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NeuroMetrix, Inc. News
04/24/24 NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year
04/19/24 NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
03/14/24 NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
03/13/24 NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quellยฎ Fibromyalgia
03/12/24 Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired
03/08/24 RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.
03/04/24 Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.
02/24/24 NeuroMetrix Full Year 2023 Earnings: US$6.08 loss per share (vs US$4.96 loss in FY 2022)
02/23/24 NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript
02/22/24 Q4 2023 NeuroMetrix Inc Earnings Call
02/22/24 NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
02/15/24 NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
02/13/24 NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value
01/09/24 Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now
01/08/24 NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
12/12/23 NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quellยฎ in Post-Acute COVID-19 Syndrome (Long COVID)
12/05/23 NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quellยฎ Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)
11/20/23 NeuroMetrix Announces One-for-Eight Reverse Stock Split
10/31/23 Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now
10/30/23 NeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023
NURO Chatroom

User Image Heywood_Jablomi Posted - 04/29/24

$NURO whatever is happening here is happening very slowly

User Image Tygalastkings187 Posted - 04/29/24

$NURO i need $30 COME ON NURO!!!!

User Image EvelynSunshine Posted - 04/26/24

$NURO need $95 more per share to earn back losses. Let's go!

User Image Heywood_Jablomi Posted - 04/23/24

$NURO this seems like itโ€™s getting set up for a major move upward

User Image Tygalastkings187 Posted - 04/23/24

$NURO THIS IS GONA RUN ๐Ÿ”ฅ

User Image Coach_B1067 Posted - 04/23/24

$NURO wow...this pos is green for the 3rd day in a row!

User Image JumpingJP Posted - 04/22/24

$NURO will probably run to $6 this week

User Image StockMET Posted - 04/22/24

$NURO we got in here early ๐Ÿ“ˆ the chart is looking for continuation

User Image WolfOfLouisiana Posted - 04/21/24

$NURO ๐Ÿบ

User Image Fullratio Posted - 04/21/24

$NURO debt is 99% lower than its equity: https://fullratio.com/stocks/nasdaq-nuro/neurometrix

User Image StockScanners Posted - 04/20/24

$NURO Keep watch if this holds above 4.25, watch 4.60 break

User Image Bigeyes2 Posted - 04/19/24

$NURO Inverted head and shoulders

User Image Heywood_Jablomi Posted - 04/19/24

$NURO $4.20, how very appropriate

User Image Tygalastkings187 Posted - 04/19/24

$NURO buy now or regret been holding thsi for 3 years now!!!

User Image Money_never_sleep Posted - 04/19/24

$NURO

User Image Stocksrunner Posted - 04/19/24

๐ŸŽ‰ Check out today's TOP GAINER making headlines: ๐ŸŒŸ $NURO - NeuroMetrix is on FIRE! ๐Ÿš€ Exciting news as they announce steps to boost shareholder value following feedback! ๐Ÿ”ฅ

User Image WolfOfLouisiana Posted - 04/19/24

$NURO ๐Ÿ‘€micro float can run like $WISA ๐Ÿบ

User Image Heywood_Jablomi Posted - 04/19/24

$NURO why is this up today

User Image WolfOfLouisiana Posted - 04/19/24

$NURO ๐Ÿ‘€ ๐Ÿบ $HOLO $TOP $VERB

User Image Knowhentoprofit Posted - 04/19/24

$NURO sonnet than later

User Image WolfOfLouisiana Posted - 04/19/24

$NURO time for another big run? ๐Ÿ‘๏ธ๐Ÿ‘๏ธ๐Ÿบ

User Image JumpingJP Posted - 04/19/24

$NURO first recommendation, fire management.

User Image StockMET Posted - 04/19/24

$NURO get ready for extreme volatility ๐Ÿ“ˆ๐Ÿš€

User Image DonCorleone77 Posted - 04/19/24

$NURO NeuroMetrix appoints Joshua Horowitz to board, terminates ATM equity facility NeuroMetrix announced two steps to enhance shareholder value following feedback and recommendations from one of its largest shareholders, Ephraim Fields of Echo Lake Capital. The Board has approved the appointment of Joshua Horowitz as a new independent director with a 1-year term. Mr. Horowitz is a professional investor with over 22 years of investing experience. Since January 2012, he has served as a portfolio manager with Palm Management. The Company has also terminated its at-the-market equity facility it had entered into with Ladenburg Thalmann & Co., Inc. on October 22, 2021.

User Image updownup Posted - 04/19/24

$NURO Wow, that must have been painful for Gozani to sign off on that PR! ๐Ÿ˜‚

User Image suphawk85 Posted - 04/19/24

$NURO What do we think are these steps going to help us recoup our investments?

User Image Stock_Titan Posted - 04/19/24

$NURO NeuroMetrix Announces Steps Taken to Enhance Shareholder Value https://www.stocktitan.net/news/NURO/neuro-metrix-announces-steps-taken-to-enhance-shareholder-2ygnu6q8k0xk.html

User Image Tygalastkings187 Posted - 04/18/24

$NURO come on nuromaterix!!! Do 1000% โœˆ๏ธ

User Image JumpingJP Posted - 04/17/24

$NURO found management!

User Image Knowhentoprofit Posted - 04/12/24

$NURO yaaawn

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
HIGGINS THOMAS T Senior Vice Presiden.. Senior Vice President, CFO Aug 02 Option 0.87 3,983 3,465 54,820 08/04/23
Gozani Shai President & CEO President & CEO Aug 02 Option 0.87 5,086 4,425 70,280 08/04/23